HOLLYWOOD, Calif., July 17, 2013 /PRNewswire/ — Medbox, Inc. (OTC Markets: MDBX) (www.medboxinc.com), a leader in providing industry specific consulting services and patented systems to the medical and retail industries, announced that it has re-filed a registration statement with the Securities & Exchange Commission as well as responded to any and all SEC comments from the company’s Form 10 filing of April 10th.
The company anticipates effectiveness of the registration statement within Q3 2013.
“The filing allows us to once again demonstrate that we are the leader and one of only a few legitimate companies catering to the medical marijuana ancillary service industry,” stated Dr. Bruce Bedrick, CEO of Medbox, “This also marks an exciting time in our company’s growth cycle. After effectiveness we will have increased access to capital and will also qualify to be listed on a different exchange. We are currently researching both the NASDAQ Global Market as well as the NYSE MKT as candidates.”
To view S-1 Filing click here.
About Medbox, Inc:
Medbox is a leader in the development, sales and service of automated, biometrically controlled dispensing and storage systems for medicine and merchandise. Medbox has offices throughout the world, including New York, Arizona, Connecticut, Massachusetts, Tokyo, London and Toronto, and has their corporate headquarters in Los Angeles.
Medbox provides their patented systems, software and consulting services to pharmacies, dispensaries, urgent care centers, drug rehab clinics, hospitals, prison systems, hospice facilities, and medical groups worldwide.
Medbox, Inc. is a publicly traded company, and is quoted on the OTC Markets, ticker symbol MDBX.
For more information on Medbox, please contact the Medbox Investor Relations Department at (800) 762-1452 or go online to www.medboxinc.com.
Forward-Looking Statements: The statements in this press release constitute forward-looking statements within the meaning of federal securities laws. Such statements are based on our current beliefs and expectations and are inherently subject to significant business, economic and competitive uncertainties and contingencies, many of which are beyond our control. In addition, such forward-looking statements are subject to assumptions with respect to future business strategies and decisions that are subject to change. Potential risks and uncertainties include, but are not limited to, technical advances in the industry, political conditions and economic conditions in the states considering such legislation. We do not take any obligation to update any forward-looking statementto reflect events or developments after a forward-looking statement was made.